目的 基于传统水煎煮工艺,研究处方中当归药材-饮片-当归补血汤水煎液中藁本内酯的量值传递关系。方法 以藁本内酯成分含量及转移率为指标,研究处方中当归药材-饮片-全方水煎液的量值传递关系。结果 当归药材、饮片及全方水煎液中藁本内酯质量分数范围分别为0.958 5%~1.572 7%、0.608 9%~0.815 6%、0.035 6%~0.055 9%;当归中挥发性成分藁本内酯从药材到饮片的转移率51.84%~66.07%,平均转移率为60.82%;饮片到全方水煎液的藁本内酯转移率4.94%~8.78%,平均转移率为6.46%。结论 传统水煎煮工艺提取的中药复方中仍保留挥发性成分,且质量均一稳定,可为含挥发性成分中药在复方制剂的工艺设计与质量控制方面提供参考。
Abstract
OBJECTIVE To analyze the quality value transmitting relationship of ligustilide between medical herbs-decoction pieces-whole decoction of Angelicae Sinensis Radix (ASR) based on traditional decoction process. METHODS The content and the transfer rate of ligustilide were used as indicators to analyze the quality value transmitting relationship between medical herbs-decoction pieces-whole decoction of ASR. RESULTS The content ranges of ligustilide in medical herbs, decoction pieces and whole decoction were 0.958 5%-1.572 7%, 0.608 9%-0.815 6% and 0.035 6%-0.055 9%. The transfer rate of ligustilide from medical herbs to decoction pieces was between 51.84% and 66.07%, the average transfer rate was 60.82%; the transfer rate of ligustilide from decoction pieces to whole decoction was between 4.94% and 8.78%, the average transfer rate was 6.46%. CONCLUSION Traditional Chinese medicine compounds based on traditional decoction process remain volatile components, and METHODS were simple, accurate, stable and sensitive,and can provide a reference for the transformation and development of modern preparations which contain volatile components.
关键词
挥发性成分 /
藁本内酯 /
当归补血汤水煎液 /
量值传递
{{custom_keyword}} /
Key words
volatile component /
ligustilide /
Danggui Buxue decoction /
quality value transmitting
{{custom_keyword}} /
中图分类号：
R283
R944
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] HU J, LI K, LI A P, et al. Research progress on material basis of Danggui Buxue Decoction [J]. Chin Tradit Herb Drugs(中草药), 2020, 51(21): 5658-5663.
[2] WANG L N, CHEN C Y, CHEN X Y, et al. Effect of Danggui Buxue Decoction on expression of transient receptor potential melastatin 7 and collagen synthesis in myocardial fibrosis tissue of uremia rats [J]. Chin J Mod Med(中国现代医学杂志), 2015, 25(30): 7-12.
[3] ZHAO J, XIA X P. Research status of chemical constituents and pharmacological effects of Angelica sinensis [J]. Chin J Clin Ration Drug Use(临床合理用药杂志), 2020, 13(6): 172-174.
[4] ZHU H, LIU L S, XIONG L, et al. Constituents of angelica oil and their neuroprotective effects [J]. Nat Prod Res Dev(天然产物研究与开发), 2020, 32(9): 1477-1483.
[5] LIU X L, HUANG X Y, ZHANG X F, et al. Q-Marker prediction of volatile oil of Angelicae Sinensis Radix based on GC-MS analysis combined with network pharmacology [J]. Chin Tradit Herb Drugs(中草药), 2021, 52(9): 2696-2706.
[6] WANG S X, SHEN X, MENG Y J, et al. Analysis of volatile oil in common components of Angelica medicinal parts by HS-SPME-GC-MS [J]. Chin J Hosp Pharm(中国医院药学杂志), 2019, 39(5): 433-438.
[7] LIN X M, YUE L D, ZHANG Z L, et al. Using GC-IMS to compare difference of specific odor components of Angelicae Sinensis Radix by different yellow wine processing methods [J]. Chin Tradit Herb Drugs(中草药), 2020, 51(17): 4464-4472.
[8] LIU X Y, LIU G X, ZHANG Y B, et al. Analysis of volatile compounds in Angelicae Sinensis Radix Fukeqianjin tablets andcapsules by SPME-GC/MS with retention index [J]. Chin J Pharm Anal(药物分析杂志), 2020, 40(4): 583-596.
[9] WANG S X, YU A M, YAN X L, et al. Analysis of volatilis components changes before and after combination in Angelica and Ligusticum by headspace solid phase microextraction gas chromatography-mass spectrometry [J]. Chin Arch Tradit Chin Med(中华中医药学刊), 2020, 38(5): 118-124.
[10] YANG L W, WANG H N, GENG L, et al. Discussion on whole quality control mode of traditional Chinese medicine based on standard decoction [J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2018, 24(8): 1-6.
[11] XIAO L. The processing of angelica sinensis[J]. Northwest Pharm J(西北药学杂志),1987,2(1): 29-30.
[12] WANG Z J, TANG L Y, SONG B S, et al. Studies of traditional Chinese pharmaceutical processe for Radix Angelicae sinensis in medical history[J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2010, 16(3): 135-138.
[13] MIN G C. The processing experience of Angelica and Ligusticum chuanxiong is introduced[J]. Bull Chin Mater Med (中药通报), 1987,12(11): 25.
[14] WU Z C, YANG X C, HANG J, et al. Preliminary study on the processing method of min Danggui folk[J]. J Gansu Coll Tradit Chin Med(甘肃中医学院学报), 2013, 30(5): 48-50.
[15] GUO R K. Traditional Chinese medicine is made of wine and vinegar[J]. J Guizhou Univ Tradit Chin Med(贵州中医学院学报), 1981,3(3): 40-45.
[16] GUO S, SHEN Q N, CAO H H, et al. Study on quality of standard decoction of Coptidis Rhizoma based on traditional decoction process [J]. China J Chin Mater Med(中国中药杂志), 2019, 44(18): 3985-3993.
[17] JIANG H G, ZHAO X K, LIN W Y, et al. Qualitative analysis of multiple cumarins in Angelicae Sinensis Radix based on HPLC-Q-TOF-MS/MS [J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2019, 25(13): 157-162.
[18] PENG Y H, DAN L, QIN Z, et al. Elucidation of transport mechanism of paeoniflorin and the influence of ligustilide, senkyunolide I and senkyunolide A on paeoniflorin transport through Mdck-Mdr1 cells as blood-brain barrier in vitro model[J]. Molecules, 2016, 21(3):300.
[19] KEUM E H, CHUNG S Y, LEE J H, et al. Development of analytical method for determination of baicalin, eleutheroside E, and ligustilide by LC-MS/MS in raw materials of health functional foods[J]. J Food Hyg Safe, 2017, 32(3):193.
[20] YAO N, WANG Z W, FU X Y, et al. Advances in research on effects of the essential oil of Angelicae Sinensis Radix and its phthalide constituents on smooth muscle [J]. Chin J Mod Appl Pharm(中国现代应用药学), 2019, 36(21): 2738-2742.
[21] LI X, XIE S D, LV L, et al. Problems and solutions in extraction of volatile oil from traditional Chinese medicine [J]. China J Tradit Chin Med Pharm(中华中医药杂志), 2006,21(3): 179-180.
[22] WU Z F, WANG S J, YANG M, et al. Research status and problem analysis of extraction process of volatile oil from traditional Chinese medicine [J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2014, 20(14): 224-228.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金项目资助(81773910, 82074004);国家重点研发计划资助(2019YFC1710603);江苏高校 “青蓝工程”项目资助(2020)
{{custom_fund}}
PDF(1703 KB)
